Triomed Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 44
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 2

Triomed General Information

Description

Developer of portable dialysis system intended to improve the lives of end-stage renal disease patients. The company's platform has developed a modular dialysis system that addresses the key reasons patients leave peritoneal dialysis and adapts to treat the patient in the different stages of their disease progression, enabling patients to get improved treatment at reduced costs.

Contact Information

Website
www.triomed.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Diagnostic Equipment
Primary Office
  • Ideon Science Park
  • Scheelevägen 17
  • 223 63 Lund
  • Sweden
+46 046-460 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Triomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 26-Jan-2012 Completed Generating Revenue
To view Triomed’s complete valuation and funding history, request access »

Triomed Patents

Triomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200164129-A1 Dialysis device comprising an evaporator/condenser device Pending 14-Jul-2017 0000000000
EP-3651828-A4 Dialysis device comprising an evaporator/condenser device Pending 14-Jul-2017 0000000000 0
EP-3651828-A1 Dialysis device comprising an evaporator/condenser device Pending 14-Jul-2017 0000000000
US-20180169318-A1 Apparatus for performing peritoneal ultrafiltration Granted 27-Aug-2015 000000000 0
AU-2016312860-B2 Apparatus for performing peritoneal ultrafiltration Active 27-Aug-2015 A61M1/28 0
To view Triomed’s complete patent history, request access »

Triomed Executive Team (4)

Name Title Board Seat Contact Info
Patrick Greatrex Chief Executive Officer
Anders Wallenas Co-Founder, Chief Scientific Officer & Board Member
Lars Wramner Co-Founder, Board Member & Director, Medical
Anders Helmner Co-Founder & Board Member
To view Triomed’s complete executive team members history, request access »

Triomed Board Members (8)

Name Representing Role Since
Anders Helmner Triomed Co-Founder & Board Member 000 0000
Anders Wallenas Triomed Co-Founder, Chief Scientific Officer & Board Member 000 0000
Juan Bosch Self Board Member 000 0000
Lars Persson Triomed Board Member 000 0000
Lars Wramner Triomed Co-Founder, Board Member & Director, Medical 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Triomed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Triomed Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
Frankenius Equity Family Office Minority 000 0000 000000 0
To view Triomed’s complete investors history, request access »